EMEA plans for 2009, more transparency

The European Medicines Agency (EMEA) has announced its work program for 2009, including moves towards greater transparency of its meetings and  data. The regulator's management board has also adopted a draft budget  for 2009 at its meeting in December 2008. One of the highlights of the  new year is the inauguration of the new Committee for Advanced  Therapies in January. Other priority areas for the Agency in 2009  include: the provision of scientific advice in the area of innovative  development methods; further strengthening of the EMEA's  pharmacovigilance activities in relation to the European Network of  Centers for Pharmacoepidemiology and Pharmacovigilance (ENCePP), risk  management plans and signal detection; and transparency and provision  of information.